Medical specialists from Netherlands tagged as investigators in clinical trials studying Squamous Cell Carcinoma of Head and Neck

Total 11 results

Anne-Marie Dingemans, MD, PhD.
Seen in:
- Rotterdam, Erasmus Medical Center
Trials:
- NCT04868877 (Principal Investigator)
Conditions:
Anthonie van der Wekken, MD, PhD
Seen in:
- Groningen, University Medical Center Groningen
- Groningen, University Medical Centre Groningen
Trials:
- NCT04868877 (Principal Investigator)
- NCT05118789 (Principal Investigator)
Conditions:
Carla van Herpen, MD
Seen in:
- Nijmegen, UMC Radboud
Trials:
- NCT03526835 (Principal Investigator)
Conditions:
frank hoebers, Dr
Seen in:
- Limburg, Maastricht, Maastro clinic
Trials:
- NCT01644786 (Sub-Investigator)
Conditions:
- Head and Neck Squamous Cell Carcinoma
Frans Opdam, MD
Seen in:
- Amsterdam, NKI
- Amsterdam, Netherlands Cancer Institute
Trials:
- NCT02912949 (Principal Investigator)
- NCT04868877 (Principal Investigator)
Conditions:
Jan Paul de Boer, MD
Seen in:
- Amsterdam, NKI - Antoni van Leeuwenhoek
Trials:
- NCT03526835 (Principal Investigator)
Conditions:
Lot Devriese, MD
Seen in:
- Utrecht, UMC Utrecht
Trials:
- NCT03526835 (Principal Investigator)
Conditions:
Neeltje Steeghs
Seen in:
- Amsterdam, Antoni Van Leeuwenhoekziekenhuis
- Amsterdam, GSK Investigational Site
- Other, Amsterdam, Antoni Van Leeuwenhoekziekenhuis
Trials:
- NCT03843359 (Principal Investigator)
- NCT05208762 (Principal Investigator)
Conditions:
Philippe Lambin, Prof
Seen in:
- Limburg, Maastricht, Maastro clinic
Trials:
- NCT01644786 (Principal Investigator)
Conditions:
- Head and Neck Squamous Cell Carcinoma
Prof. dr. R.P. Takes, MD, PhD
Seen in:
- Nijmegen, Radboud University Nijmegen Medical Center
Trials:
- NCT05333523 (Sub-Investigator)
Conditions:
Stijn Keereweer, MD PhD
Seen in:
- Zuid-Holland, Rotterdam, Erasmus University Medical Center
Trials:
- NCT04191460 (Principal Investigator)
Conditions:

Clinical Trials on Squamous Cell Carcinoma of Head and Neck

Washington University School of Medicine
Merck Sharp & Dohme LLC

Active, not recruiting

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Head and Neck Cancer | Squamous Cell Carcinoma of the Head and Neck | Cancer of Head and Neck | Carcinoma, Squamous Cell of Head and Neck | Neoplasms, Head and Neck | Squamous Cell Carcinoma, Head and Neck

United States
Washington University School of Medicine
Celgene Corporation

Active, not recruiting

Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC) (APA)

Head and Neck Cancer | Squamous Cell Carcinoma of the Head and Neck | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and Neck | Carcinoma, Squamous Cell of the Head and Neck

United States
Bristol-Myers Squibb

Active, not recruiting

A Study of Nivolumab in Patients With Head and Neck Cancer. (ProNiHN)

Squamous Cell Carcinoma of the Head and Neck; Head and Neck Cancer; Head and Neck Carcinoma; Cancer of the Head and Neck

France
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Recruiting

Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition

Recurrent Head and Neck Squamous Cell Carcinoma | Advanced Head and Neck Squamous Cell Carcinoma | Metastatic Head-and-neck Squamous-cell Carcinoma | Locally Advanced Head and Neck Squamous Cell Carcinoma | Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck | Stage IV Cutaneous...

United States
University of Pittsburgh
National Cancer Institute (NCI)

Terminated

Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma

Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma, Head And Neck | Carcinoma, Squamous Cell of Head and Neck

United States
National Cancer Institute (NCI)

Not yet recruiting

Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma

Stage II Squamous Cell Carcinoma of the Head and Neck | Stage III Squamous Cell Carcinoma of the Head and Neck | Stage IV Squamous Cell Carcinoma of the Head and Neck

United States
Eben Rosenthal
National Cancer Institute (NCI)

Completed

Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer

Head and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Squamous Cell Carcinoma of the Head and Neck (SCCHN)

United States
Case Comprehensive Cancer Center

Not yet recruiting

ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck

Head and Neck Squamous Cell Carcinoma | Recurrent Squamous Cell Carcinoma of the Head and Neck | Metastatic Squamous Cell Carcinoma

United States
Washington University School of Medicine

Active, not recruiting

Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies

Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma, Head and Neck

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery

Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck | Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck | Stage...

United States

Medical specialists from Netherlands tagged as investigators in clinical trials studying Squamous Cell Carcinoma of Head and Neck

Clinical Trials on Squamous Cell Carcinoma of Head and Neck

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations